Literature DB >> 24030458

Pigment epithelium-derived factor decreases outflow facility.

Morgan E Rogers1, Iris D Navarro, Kristin M Perkumas, Shannon M Niere, R Rand Allingham, Craig E Crosson, W Daniel Stamer.   

Abstract

PURPOSE: Pigment epithelium-derived factor (PEDF) regulates blood-retinal barrier function. As a constituent of aqueous humor, the role of PEDF in conventional outflow function is unknown. The goals of the study were to examine the effects of PEDF on barrier function of cultured Schlemm's canal (SC) endothelia and outflow facility in mouse eyes in situ.
METHODS: To model the inner wall of SC, transendothelial electrical resistance (TEER) of human SC and porcine angular aqueous plexus (AAP) cells was monitored. To examine an intact conventional outflow pathway, enucleated eyes from culled C57BL/6 mice were perfused with PEDF using a computer-controlled system. Purified PEDF (0.1 and 1 μg/mL) was perfused at four different pressure steps (4, 8, 15, 20 mm Hg), measuring flow to determine outflow facility (slope of flow/pressure relationship).
RESULTS: Pigment epithelium-derived factor increased TEER of porcine AAP cells in a dose-dependent fashion (0.3-3 μg/mL), and 1 μg/mL recombinant PEDF or conditioned media from pigmented retinal pigment epithelial monolayers stabilized TEER of human SC monolayers over time (0-48 hours). In perfusion experiments, we observed a 43.7% decrease in outflow facility (0.016 vs. 0.029 μL/min/mm Hg, P = 4.5 × 10⁻⁵) in eyes treated with 1 μg/mL PEDF compared to vehicle-perfused controls, and a 19.9% decrease (0.021 vs. 0.027 μL/min/mm Hg, P = 0.003) at 100 ng/mL PEDF.
CONCLUSIONS: Pigment epithelium-derived factor increased barrier function in both the in vitro and in situ models of the inner wall of SC. Modification of PEDF signaling in SC cells may be therapeutically exploited to increase outflow facility in people with ocular hypertension or decrease outflow facility in those with hypotony.

Entities:  

Keywords:  PEDF; Schlemm's canal; VEGF; aqueous humor; glaucoma; growth factors; outflow facility; trabecular meshwork

Mesh:

Substances:

Year:  2013        PMID: 24030458      PMCID: PMC3796938          DOI: 10.1167/iovs.13-12766

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  34 in total

1.  Pharmacologic manipulation of conventional outflow facility in ex vivo mouse eyes.

Authors:  Alexandra Boussommier-Calleja; Jacques Bertrand; David F Woodward; C Ross Ethier; W Daniel Stamer; Darryl R Overby
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-24       Impact factor: 4.799

2.  Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1.

Authors:  Jun Cai; Wen G Jiang; Maria B Grant; Mike Boulton
Journal:  J Biol Chem       Date:  2005-12-08       Impact factor: 5.157

3.  Human retinal pigment epithelium cells as functional models for the RPE in vivo.

Authors:  Zsolt Ablonczy; Mohammad Dahrouj; Peter H Tang; Yueying Liu; Kumar Sambamurti; Alan D Marmorstein; Craig E Crosson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-04       Impact factor: 4.799

4.  Outflow physiology of the mouse eye: pressure dependence and washout.

Authors:  Yuan Lei; Darryl R Overby; Alexandra Boussommier-Calleja; W Daniel Stamer; C Ross Ethier
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-29       Impact factor: 4.799

5.  A new method for selection of angular aqueous plexus cells from porcine eyes: a model for Schlemm's canal endothelium.

Authors:  Yuan Lei; Darryl R Overby; A Thomas Read; W Daniel Stamer; C Ross Ethier
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-16       Impact factor: 4.799

6.  Low levels of pigment epithelium-derived factor in highly myopic eyes with chorioretinal atrophy.

Authors:  Nahoko Ogata; Masahito Imaizumi; Miki Miyashiro; Miwa Arichi; Masato Matsuoka; Akira Ando; Miyo Matsumura
Journal:  Am J Ophthalmol       Date:  2005-11       Impact factor: 5.258

7.  Global data on visual impairment in the year 2002.

Authors:  Serge Resnikoff; Donatella Pascolini; Daniel Etya'ale; Ivo Kocur; Ramachandra Pararajasegaram; Gopal P Pokharel; Silvio P Mariotti
Journal:  Bull World Health Organ       Date:  2004-12-14       Impact factor: 9.408

8.  Endogenous Bioactive Lipids and the Regulation of Conventional Outflow Facility.

Authors:  Zhou Wan; David F Woodward; W Daniel Stamer
Journal:  Expert Rev Ophthalmol       Date:  2008

9.  Sphingosine-1-phosphate effects on the inner wall of Schlemm's canal and outflow facility in perfused human eyes.

Authors:  W Daniel Stamer; A Thomas Read; Grant M Sumida; C Ross Ethier
Journal:  Exp Eye Res       Date:  2009-08-27       Impact factor: 3.467

10.  Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes.

Authors:  A F Clark; K Wilson; A W de Kater; R R Allingham; M D McCartney
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-02       Impact factor: 4.799

View more
  10 in total

1.  High-throughput screening for modulators of cellular contractile force.

Authors:  Chan Young Park; Enhua H Zhou; Dhananjay Tambe; Bohao Chen; Tera Lavoie; Maria Dowell; Anton Simeonov; David J Maloney; Aleksandar Marinkovic; Daniel J Tschumperlin; Stephanie Burger; Matthew Frykenberg; James P Butler; W Daniel Stamer; Mark Johnson; Julian Solway; Jeffrey J Fredberg; Ramaswamy Krishnan
Journal:  Integr Biol (Camb)       Date:  2015-05-08       Impact factor: 2.192

2.  Direct measurement of pressure-independent aqueous humour flow using iPerfusion.

Authors:  Michael Madekurozwa; Ester Reina-Torres; Darryl R Overby; Joseph M Sherwood
Journal:  Exp Eye Res       Date:  2017-07-16       Impact factor: 3.467

3.  The structure of the trabecular meshwork, its connections to the ciliary muscle, and the effect of pilocarpine on outflow facility in mice.

Authors:  Darryl R Overby; Jacques Bertrand; Martin Schicht; Friedrich Paulsen; W Daniel Stamer; Elke Lütjen-Drecoll
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-15       Impact factor: 4.799

Review 4.  The vital role for nitric oxide in intraocular pressure homeostasis.

Authors:  Ester Reina-Torres; Michael L De Ieso; Louis R Pasquale; Michael Madekurozwa; Joseph van Batenburg-Sherwood; Darryl R Overby; W Daniel Stamer
Journal:  Prog Retin Eye Res       Date:  2020-11-28       Impact factor: 21.198

5.  VEGF as a Paracrine Regulator of Conventional Outflow Facility.

Authors:  Ester Reina-Torres; Joanne C Wen; Katy C Liu; Guorong Li; Joseph M Sherwood; Jason Y H Chang; Pratap Challa; Cassandra M Flügel-Koch; W Daniel Stamer; R Rand Allingham; Darryl R Overby
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-03-01       Impact factor: 4.799

6.  Plexin domain containing 2 (PLXDC2) gene polymorphism rs7081455 may not influence POAG risk in a Saudi cohort.

Authors:  Altaf A Kondkar; Tahira Sultan; Faisal A Almobarak; Hatem Kalantan; Khaled K Abu-Amero; Saleh A Al-Obeidan
Journal:  BMC Res Notes       Date:  2018-10-16

7.  The Soluble Guanylate Cyclase Stimulator IWP-953 Increases Conventional Outflow Facility in Mouse Eyes.

Authors:  Pei Ge; Iris D Navarro; Marco M Kessler; Sylvie G Bernier; Nicholas R Perl; Renee Sarno; Jaime Masferrer; Gerhard Hannig; W Daniel Stamer
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-03       Impact factor: 4.799

8.  Dose- and time-dependent effects of actomyosin inhibition on live mouse outflow resistance and aqueous drainage tissues.

Authors:  MinHee K Ko; Eun Kyoung Kim; Jose M Gonzalez; James C Tan
Journal:  Sci Rep       Date:  2016-02-17       Impact factor: 4.379

9.  Administration of Pigment Epithelium-Derived Factor Inhibits Airway Inflammation and Remodeling in Chronic OVA-Induced Mice via VEGF Suppression.

Authors:  Wangjian Zha; Mei Su; Mao Huang; Jiankang Cai; Qiang Du
Journal:  Allergy Asthma Immunol Res       Date:  2015-11-02       Impact factor: 5.764

10.  Aqueous Humor Outflow Requires Active Cellular Metabolism in Mice.

Authors:  Ester Reina-Torres; Alexandra Boussommier-Calleja; Joseph M Sherwood; Darryl R Overby
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.